ANTIBODY MOLECULES TO ONCOGENIC ISOFORMS OF FIBROBLAST GROWTH FACTOR RECEPTOR-2 AND USES THEREOF - Patent 2603521

(19)

(11)

EP 2 603 521 A2

(12)

(88)	Date of publication A3:
	14.06.2012

(43)	Date of publication:
	19.06.2013 Bulletin 2013/25

(21)	Application number: 11817134.7

(22)	Date of filing: 12.08.2011

(51)

International Patent Classification (IPC):

C07K 16/00^(2006.01)

A61K 39/395^(2006.01)

(86)	International application number:
	PCT/US2011/047650

(87)	International publication number:
	WO 2012/021841 (16.02.2012 Gazette 2012/07)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

12.08.2010 US 373072 P

(71)	Applicant: Attogen Inc.
	Worcester, MA 01606 (US)

(72)	Inventors:
	CHANG, Xiao-Jia Lincoln, MA 01773 (US) SCHWERTSCHLAG, Ullrich, S. Indian Creek, IL 60061 (US) TURNER, Katherine, Jane Acton, MA 01720 (US)

(74)	Representative: Williams, Gareth Owen
	Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA Cambridge CB2 1LA (GB)

(54)	ANTIBODY MOLECULES TO ONCOGENIC ISOFORMS OF FIBROBLAST GROWTH FACTOR RECEPTOR-2 AND USES THEREOF